Metabolic Differences between CSII and MDI in Type 1 Diabetes Mexican Patients from the Multicentric Study RENACED

被引：0
|
作者：
Faradji, Raquel N.
Valenzuela-Lara, Marisol
Bustamante-Martinez, Jorge F.
Cecena-Gonzalez, Martha P.
De la Garza-Hernandez, Natalia E.
Escobedo-Ortiz, Ana
Ferreira Hermosillo, Aldo
Figueroa-Andrade, Mario H.
Flores-Camargo, Areli
Garcia-Manzanarez, Raquel
Gomez-Cruz, Jose R.
Gonzalez-Galvez, Guillermo
Islas-Ortega, Laura
Lopez-Miramontes, Claudia
Martinez-Ramos, Angelica
Mendoza-Romo, Miguel A.
Miracle-Lopez, Sigfrido
Polanco-Preza, Miguel A.
Rangel-Guerrero, Hugo G.
Rodriguez-Sanchez, Ester
Romero-Zazueta, Alejandro
Tavera-Hernandez, Marcela
Valenzuela-Montoya, Julio C.
Vidrio-Velazquez, Maricela
Yepez-Rodriguez, Alicia E.
Nino-Vargas, Ricardo S.
Sainz De la Maza-Viadero, Maria E.
Magis-Rodriguez, Carlos
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
128-LB
引用
收藏
页码：LB33 / LB34
页数：2
相关论文
共 50 条
  • [21] STUDY DESIGN OF RANDOMIZED, ADAPTIVE TRIAL IN ADULT AND PEDIATRIC PATIENTS WITH TYPE 1 DIABETES USING HYBRID CLOSED LOOP VERSUS CONTROL (CSII, MDI OR SAP)
    Shin, J.
    Huang, S.
    Troub, T.
    Lee, S.
    Cordero, T.
    Kaufman, F.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A84 - A84
  • [22] Glycemic patterns detected by continuous subcutaneous glucose sensing in children with type 1 diabetes treated by MDI or CSII
    Weintrob, N
    Schechter, A
    Bezaquen, H
    Shalitin, S
    Lilos, P
    Galatzer, A
    Phillip, M
    [J]. DIABETES, 2003, 52 : A100 - A100
  • [23] CORRELATION BETWEEN FREQUENCY OF SMBG AND GLYCEMIC CONTROL IN TYPE 1 DIABETIC SUBJECTS WITH CSII AND MDI THERAPY
    Scarpitta, A. M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A112 - A112
  • [24] CSII is associated with lower NAFLD indices in patients with type 1 diabetes
    Bozzetto, L.
    Della Pepa, G.
    Raso, E.
    Boccia, R.
    Gianfrancesco, S.
    Rivellese, A. A.
    Annuzzi, G.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S8 - S8
  • [25] THE METABOLIC CONTROL IN CHILDREN WITH TYPE 1 DIABETES TREATED WITH CSII - IMPACT OF THE DISEASE DURATION
    Zubkiewicz-Kucharska, A.
    Stepkowski, M.
    Seifert, M.
    Jonak, O.
    Kaczmarzyk, A.
    Marczak, E.
    Chrzanowska, J.
    Noczynska, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A133 - A133
  • [26] Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study
    Schreiver, C.
    Jacoby, U.
    Watzer, B.
    Thomas, A.
    Haffner, D.
    Fischer, D. -C.
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 79 (05) : 641 - 647
  • [27] A COMPARISON OF GLYCEMIC VARIABILITY IN CSII VS MDI IN PEOPLE WITH TYPE 1 DIABETES: A REAL-WORLD DATA ANALYSIS
    Mourad, S.
    Irshad, M.
    Baqer, A.
    Azizieh, M.
    Al Kandari, J.
    Al Ozairi, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A188 - A188
  • [28] Effect of the Omnipod® Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII
    Mehta, Sanjeev N.
    Kruger, Davida F.
    Bode, Bruce W.
    Layne, Jennifer E.
    Dumais, Bonnie
    Gallagher, Jack R.
    Ly, Trang T.
    [J]. DIABETES, 2019, 68
  • [29] A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS
    Simon, B.
    Treat, V.
    Marco, C.
    Rosenberg, D.
    Joseph, J.
    Hipszer, B.
    Li, Y.
    Chervoneva, I.
    Padron-Massara, L.
    Jabbour, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (12) : 1858 - 1863
  • [30] Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Petrizzo, Michela
    Improta, Maria Rosaria
    Brancario, Clementina
    Castaldo, Filomena
    Olita, Laura
    Giugliano, Dario
    Esposito, Katherine
    [J]. ENDOCRINE, 2014, 46 (02) : 256 - 262
12345